[1]
I. AlShoaibi, “Effect of DOPA decarboxylase inhibitor supplements on the incidence of urinary tract infections in Parkinson’s disease patients: A systematic review and meta-analysis of randomized controlled trials”, Arch Ital Urol Androl, Oct. 2024.